The PI3K/Akt/mTOR signaling pathway in gastric cancer; from oncogenic variations to the possibilities for pharmacologic interventions

ABS Khorasani, A Pourbagheri-Sigaroodi… - European Journal of …, 2021 - Elsevier
Genetic and epigenetic alterations have been under concentrated investigations for many
years in order to unearth the molecules regulating human cancer pathogenesis. However …

The PI3K/Akt/mTORC signaling axis in head and neck squamous cell carcinoma: Possibilities for therapeutic interventions either as single agents or in combination …

N Akbari Dilmaghani, A Safaroghli‐Azar… - IUBMB …, 2021 - Wiley Online Library
The latest advances in the sequencing methods in head and neck squamous cell carcinoma
(HNSCC) tissues have revolutionized our understanding of the disease by taking off the veil …

Liposomal formulation of new arsenic schiff base complex as drug delivery agent in the treatment of acute promyelocytic leukemia and quantum chemical and docking …

M Iraji, M Salehi, RE Malekshah, A Khaleghian… - Journal of Drug Delivery …, 2022 - Elsevier
The paper describes the synthesis of a new Schiff base As (III) complex followed by the
encapsulation of Schiff base As (III) complex in liposomes. First, As (III) Schiff base complex …

Nanomedicine for targeting the lung cancer cells by interpreting the signaling pathways

M Habeeb, TA Kareem, KL Deepthi, VS Khot… - Journal of Drug Delivery …, 2022 - Elsevier
Lung malignancy is one of the prominent causes of cancer death worldwide. However, the
treatment and diagnosis of various lung cancer becoming increasingly challenging …

Mechanistic effects of arsenic trioxide on acute promyelocytic leukemia and other types of leukemias

S Yousefnia - Cell Biology International, 2021 - Wiley Online Library
Acute promyelocytic leukemia (APL), a subtype of acute myeloid leukemia characterized
with a translocation between promyelocytic leukemia gene (PML) on chromosome 15 and …

[HTML][HTML] Research update on the anticancer effects of buparlisib

J Xing, J Yang, Y Gu, J Yi - Oncology Letters, 2021 - spandidos-publications.com
Buparlisib is a highly efficient and selective PI3K inhibitor and a member of the 2, 6‑
dimorpholinopyrimidine‑derived family of compounds. It selectively inhibits four isomers of …

Anticancer effect of pan-PI3K inhibitor on multiple myeloma cells: Shedding new light on the mechanisms involved in BKM120 resistance

A Safaroghli-Azar, D Bashash, A Kazemi… - European journal of …, 2019 - Elsevier
The correlation between the Phosphoinositide 3-kinase (PI3K) axis and crucial mechanisms
involved in the maintenance of the neoplastic nature of multiple myeloma (MM) has recently …

Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO)

F Alipour, N Riyahi, A Safaroghli-Azar, S Sari… - The international journal …, 2019 - Elsevier
Although conventional therapeutic approaches have brought remarkable advantages for the
treatment of breast cancer (BC), drug-resistance still remains as a leading cause of tumor …

[HTML][HTML] Mechanistic update of Trisenox in blood cancer

S Benerjee, PB Tchounwou, S Kumar - Current Research in …, 2023 - Elsevier
Acute promyelocytic leukemia (APL)/blood cancer is M3 type of acute myeloid leukemia
(AML) formed inside bone marrow through chromosomal translocation mutation usually …

[HTML][HTML] Integrated bioinformatics analysis and network pharmacology to explore the potential mechanism of Patrinia heterophylla Bunge against acute promyelocytic …

L Feng, S Zhu, J Ma, Y Hong, M Wan, Q Qiu, H Li, J Li - Medicine, 2023 - journals.lww.com
Methods: Public databases were used to search for bioactive compounds in PHEB, their
potential targets, differentially expressed genes associated with APL, and therapeutic targets …